The Carlsbad-based company developed the formula to address a range of symptoms, including hot flashes and mood instability, using a blend of seven non-GMO bioactives. According to internal research, the single-daily dose outperformed two other candidate formulas during testing. While these early findings are promising, the company notes that the study was not placebo-controlled, indicating that further large-scale clinical trials are necessary to confirm long-term efficacy.
In section Releases
Qualia Unveils Single-Capsule Solution for Perimenopause
A 28-day human study suggests a new hormone-free capsule from Qualia Life Sciences may reduce the physical and emotional burden of perimenopause by 62%. The product, which hit the market September 29, aims to replace the fragmented supplement regimens women have historically relied upon to manage hormonal shifts and sleep disruption.

Sara Adães, a senior research scientist at Qualia, described the transition as a demanding period that requires a more grounded approach to wellness. CEO James Schmachtenberger positioned the launch as a move to simplify health management, noting that consumers previously had to combine numerous products to achieve similar results. The supplement is now available through the company’s website, Amazon, and select retail outlets, including GNC and The Vitamin Shoppe.
Comments (0)
No comments yet. Be the first!